middle.news
How Amplia’s Narmafotinib Is Shaping the Future of Pancreatic Cancer Treatment
1:14am on Monday 2nd of June, 2025 AEST
•
Healthcare
Read Story
How Amplia’s Narmafotinib Is Shaping the Future of Pancreatic Cancer Treatment
1:14am on Monday 2nd of June, 2025 AEST
Key Points
ACCENT Phase 2a trial fully enrolled two months early with 55 patients
15 confirmed partial responses demonstrating promising efficacy
Initiation of US-based FOLFIRINOX combination trial underway
FDA Fast Track Designation granted for narmafotinib
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Amplia Therapeutics (ASX:ATX)
OPEN ARTICLE